ArticleFoods (Basel, Switzerland)2026
A Novel Polysaccharide from Walnut Dregs: Structural Features and Immunomodulatory Effects via Activation of MAPK Signaling Pathway.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
A novel acidic polysaccharide (WDP) was purified from walnut dregs, and its structural characteristics and immunomodulatory function were investigated. WDP had a weight-average molecular weight (Mw) of 351.94 kDa and consisted mainly of rhamnose, arabinose, galactose, glucose, xylose, mannose, galacturonic acid, and glucuronic acid. Methylation and NMR analyses further demonstrated that the backbone of WDP comprised →4)-α-D-GalpA-(1→, →3,6)-β-D-Galp-(1→, →6)-β-D-Galp-(1→, →4)-β-D-Galp-(1→, and →4)-α-D-Glcp-(1→ residues, with branched chains consisting of terminal α-L-Araf-(1→ residues or α-L-Araf-(1→5)-α-L-Araf-(1→ fragments attached to the O-3 position of →3,6)-β-D-Galp-(1→ residues. In vitro assays indicated that WDP modulated immune responses in RAW264.7 cells by enhancing their phagocytosis; increasing NO release and the secretion of IL-1β, IL-6 and TNF-α; and activating the MAPK signaling pathway, suggesting its potential as an immunomodulatory agent. These results provide a scientific foundation for the development of walnut dregs-derived functional foods with immune-enhancing properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.